Burning Research Development vs Other Operating Expenses Analysis

BNR Stock

USD 6.16 0.85 16.01%

Burning Rock financial indicator trend analysis is way more than just evaluating Burning Rock Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Burning Rock Biotech is a good investment. Please check the relationship between Burning Rock Research Development and its Other Operating Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burning Rock Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Research Development vs Other Operating Expenses

Research Development vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Burning Rock Biotech Research Development account and Other Operating Expenses. At this time, the significance of the direction appears to have totally related.

The correlation between Burning Rock's Research Development and Other Operating Expenses is 1.0. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Burning Rock Biotech, assuming nothing else is changed. The correlation between historical values of Burning Rock's Research Development and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Burning Rock Biotech are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Research Development i.e., Burning Rock's Research Development and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Burning Rock Biotech. It is also known as Burning Rock overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most indicators from Burning Rock's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Burning Rock Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burning Rock Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of 11/29/2024, Tax Provision is likely to grow to about 3.4 M, while Selling General Administrative is likely to drop slightly above 327.9 M.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	47.8M	124.1M	133.4M	140.1M
Interest Income	3.5M	9.5M	15.3M	10.0M

Depreciation And Amortization Interest Income

Burning Rock fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Capital Lease Obligations
Common Stock Shares Outstanding		-0.03	0.31	0.02	0.19	-0.1	0.07	-0.16	0.14	-0.13	0.05	0.46	0.2	-0.06	0.15	0.34	-0.1	0.21	-0.06	-0.08	-0.37	0.14	0.21	0.3	-0.17	0.38
Total Assets	-0.03		-0.81	0.77	0.27	0.96	0.49	0.94	0.73	0.68	-0.99	-0.61	0.83	0.99	0.75	0.81	0.84	-0.84	0.99	0.59	0.84	0.47	-0.84	-0.68	0.79	0.55
Short Long Term Debt Total	0.31	-0.81		-0.81	-0.08	-0.76	-0.4	-0.79	-0.64	-0.76	0.79	0.86	-0.6	-0.74	-0.67	-0.54	-0.79	0.99	-0.76	-0.87	-0.9	-0.37	0.99	0.53	-0.96	-0.39
Other Current Liab	0.02	0.77	-0.81		0.61	0.78	0.62	0.78	0.89	0.93	-0.76	-0.83	0.87	0.73	0.89	0.76	0.85	-0.83	0.68	0.74	0.85	0.02	-0.83	-0.68	0.8	0.74
Total Current Liabilities	0.19	0.27	-0.08	0.61		0.39	0.62	0.36	0.69	0.66	-0.27	-0.41	0.71	0.31	0.63	0.52	0.47	-0.1	0.18	0.03	0.4	-0.63	-0.1	-0.65	0.05	0.7
Total Stockholder Equity	-0.1	0.96	-0.76	0.78	0.39		0.52	0.99	0.72	0.75	-0.99	-0.67	0.83	0.99	0.72	0.79	0.86	-0.77	0.96	0.46	0.89	0.3	-0.77	-0.83	0.75	0.55
Other Liab	0.07	0.49	-0.4	0.62	0.62	0.52		0.53	0.88	0.77	-0.47	-0.53	0.77	0.47	0.87	0.78	0.84	-0.45	0.38	0.43	0.56	-0.3	-0.45	-0.52	0.45	0.9
Net Tangible Assets	-0.16	0.94	-0.79	0.78	0.36	0.99	0.53		0.71	0.78	-0.97	-0.72	0.79	0.97	0.7	0.75	0.88	-0.79	0.93	0.47	0.92	0.27	-0.79	-0.85	0.79	0.53
Property Plant And Equipment Net	0.14	0.73	-0.64	0.89	0.69	0.72	0.88	0.71		0.9	-0.69	-0.68	0.95	0.68	1.0	0.9	0.91	-0.69	0.61	0.64	0.74	-0.1	-0.69	-0.62	0.65	0.94
Current Deferred Revenue	-0.13	0.68	-0.76	0.93	0.66	0.75	0.77	0.78	0.9		-0.69	-0.9	0.82	0.66	0.88	0.72	0.91	-0.76	0.57	0.65	0.88	-0.2	-0.76	-0.77	0.76	0.76
Net Debt	0.05	-0.99	0.79	-0.76	-0.27	-0.99	-0.47	-0.97	-0.69	-0.69		0.61	-0.8	-0.99	-0.71	-0.8	-0.84	0.81	-0.98	-0.52	-0.85	-0.45	0.81	0.73	-0.79	-0.53
Retained Earnings	0.46	-0.61	0.86	-0.83	-0.41	-0.67	-0.53	-0.72	-0.68	-0.9	0.61		-0.59	-0.58	-0.67	-0.42	-0.79	0.81	-0.53	-0.69	-0.93	0.14	0.82	0.73	-0.78	-0.42
Accounts Payable	0.2	0.83	-0.6	0.87	0.71	0.83	0.77	0.79	0.95	0.82	-0.8	-0.59		0.81	0.95	0.93	0.87	-0.65	0.75	0.51	0.74	0.02	-0.65	-0.7	0.59	0.88
Cash	-0.06	0.99	-0.74	0.73	0.31	0.99	0.47	0.97	0.68	0.66	-0.99	-0.58	0.81		0.69	0.78	0.82	-0.76	0.99	0.46	0.84	0.41	-0.76	-0.76	0.72	0.51
Non Current Assets Total	0.15	0.75	-0.67	0.89	0.63	0.72	0.87	0.7	1.0	0.88	-0.71	-0.67	0.95	0.69		0.91	0.91	-0.73	0.64	0.7	0.73	-0.02	-0.73	-0.57	0.68	0.93
Non Currrent Assets Other	0.34	0.81	-0.54	0.76	0.52	0.79	0.78	0.75	0.9	0.72	-0.8	-0.42	0.93	0.78	0.91		0.85	-0.62	0.74	0.51	0.61	0.2	-0.62	-0.53	0.62	0.91
Other Assets	-0.1	0.84	-0.79	0.85	0.47	0.86	0.84	0.88	0.91	0.91	-0.84	-0.79	0.87	0.82	0.91	0.85		-0.82	0.76	0.66	0.89	0.07	-0.82	-0.73	0.82	0.78
Long Term Debt	0.21	-0.84	0.99	-0.83	-0.1	-0.77	-0.45	-0.79	-0.69	-0.76	0.81	0.81	-0.65	-0.76	-0.73	-0.62	-0.82		-0.78	-0.9	-0.87	-0.42	1.0	0.49	-0.97	-0.47
Cash And Short Term Investments	-0.06	0.99	-0.76	0.68	0.18	0.96	0.38	0.93	0.61	0.57	-0.98	-0.53	0.75	0.99	0.64	0.74	0.76	-0.78		0.49	0.8	0.54	-0.78	-0.66	0.73	0.44
Net Receivables	-0.08	0.59	-0.87	0.74	0.03	0.46	0.43	0.47	0.64	0.65	-0.52	-0.69	0.51	0.46	0.7	0.51	0.66	-0.9	0.49		0.63	0.34	-0.9	-0.15	0.86	0.49
Common Stock Total Equity	-0.37	0.84	-0.9	0.85	0.4	0.89	0.56	0.92	0.74	0.88	-0.85	-0.93	0.74	0.84	0.73	0.61	0.89	-0.87	0.8	0.63		0.08	-0.87	-0.85	0.83	0.48
Short Term Investments	0.14	0.47	-0.37	0.02	-0.63	0.3	-0.3	0.27	-0.1	-0.2	-0.45	0.14	0.02	0.41	-0.02	0.2	0.07	-0.42	0.54	0.34	0.08		-0.41	0.23	0.42	-0.15
Long Term Debt Total	0.21	-0.84	0.99	-0.83	-0.1	-0.77	-0.45	-0.79	-0.69	-0.76	0.81	0.82	-0.65	-0.76	-0.73	-0.62	-0.82	1.0	-0.78	-0.9	-0.87	-0.41		0.49	-0.97	-0.47
Non Current Liabilities Total	0.3	-0.68	0.53	-0.68	-0.65	-0.83	-0.52	-0.85	-0.62	-0.77	0.73	0.73	-0.7	-0.76	-0.57	-0.53	-0.73	0.49	-0.66	-0.15	-0.85	0.23	0.49		-0.47	-0.44
Capital Surpluse	-0.17	0.79	-0.96	0.8	0.05	0.75	0.45	0.79	0.65	0.76	-0.79	-0.78	0.59	0.72	0.68	0.62	0.82	-0.97	0.73	0.86	0.83	0.42	-0.97	-0.47		0.47
Capital Lease Obligations	0.38	0.55	-0.39	0.74	0.7	0.55	0.9	0.53	0.94	0.76	-0.53	-0.42	0.88	0.51	0.93	0.91	0.78	-0.47	0.44	0.49	0.48	-0.15	-0.47	-0.44	0.47

Click cells to compare fundamentals

Burning Rock Account Relationship Matchups

Burning Rock fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	86.8M	68.6M	104.2M	103.9M	10.2M	9.7M
Total Assets	847.6M	2.7B	2.3B	1.6B	1.0B	1.6B
Short Long Term Debt Total	67.5M	46.9M	86.7M	50.8M	12.3M	11.7M
Other Current Liab	54.1M	76.7M	120.2M	162.8M	84.3M	97.1M
Total Current Liabilities	164.4M	241.5M	372.2M	411.5M	263.4M	318.6M
Total Stockholder Equity	(891.5M)	2.4B	1.8B	1.2B	768.4M	861.3M
Other Liab	991K	491K	11.8M	4.1M	4.7M	4.3M
Net Tangible Assets	(891.8M)	2.4B	1.8B	1.2B	1.3B	862.0M
Property Plant And Equipment Net	89.3M	111.5M	406.4M	300.0M	144.2M	205.5M
Current Deferred Revenue	53.6M	75.5M	143.8M	149.4M	131.7M	112.2M
Net Debt	(26.8M)	(1.8B)	(1.3B)	(854.7M)	(602.8M)	(632.9M)
Retained Earnings	(946.5M)	(1.4B)	(2.2B)	(3.2B)	(3.9B)	(3.7B)
Accounts Payable	12.3M	35.5M	63.1M	50.9M	18.1M	36.0M
Cash	94.2M	1.9B	1.4B	905.5M	615.1M	923.0M
Non Current Assets Total	140.8M	139.4M	457.6M	328.7M	155.9M	238.7M
Non Currrent Assets Other	11.0M	23.0M	45.1M	26.0M	10.4M	9.9M
Other Assets	11.0M	23.0M	45.1M	26.0M	29.9M	24.8M
Cash And Short Term Investments	408.2M	2.3B	1.5B	905.5M	615.1M	1.1B
Net Receivables	208.5M	110.8M	161.4M	170.2M	149.6M	161.9M
Short Term Investments	314.0M	362.1M	63.8M	2.1M	13.4M	12.7M
Liabilities And Stockholders Equity	847.6M	2.7B	2.3B	1.6B	1.0B	1.6B
Non Current Liabilities Total	1.6B	491K	61.1M	17.7M	8.2M	7.8M
Capital Lease Obligations	9.7M	4.8M	84.3M	50.8M	12.3M	11.7M
Inventory	58.1M	68.0M	123.2M	130.3M	69.0M	91.3M
Other Current Assets	1.3M	51.1M	41.2M	52.8M	32.2M	33.0M
Other Stockholder Equity	(1.5B)	4.0B	4.3B	4.5B	4.8B	3.0B
Total Liab	1.7B	242.0M	433.3M	429.1M	271.6M	258.0M
Net Invested Capital	(833.7M)	2.5B	1.8B	1.2B	768.4M	928.4M
Long Term Investments	40.2M	1.4M	910K	690K	337K	320.2K
Property Plant And Equipment Gross	89.3M	111.5M	406.4M	300.0M	548.3M	279.6M
Total Current Assets	706.8M	2.5B	1.8B	1.3B	884.1M	1.4B
Accumulated Other Comprehensive Income	9.3M	(167.6M)	(207.1M)	(165.7M)	(161.5M)	(169.6M)
Net Working Capital	542.3M	2.3B	1.4B	847.3M	620.7M	1.1B
Short Term Debt	44.4M	46.9M	37.4M	37.2M	8.6M	8.2M
Intangible Assets	343K	3.5M	5.2M	161K	964K	915.8K
Property Plant Equipment	89.3M	111.5M	406.4M	300.0M	345.0M	214.9M

Pair Trading with Burning Rock

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burning Rock position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burning Rock will appreciate offsetting losses from the drop in the long position's value.

Moving against Burning Stock

0.69	GANX	Gain Therapeutics	Pair Corr
0.6	BHC	Bausch Health Companies	Pair Corr
0.49	EWTX	Edgewise Therapeutics	Pair Corr
0.48	HCM	HUTCHMED DRC	Pair Corr
0.35	PFE	Pfizer Inc Aggressive Push	Pair Corr

The ability to find closely correlated positions to Burning Rock could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burning Rock when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burning Rock - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burning Rock Biotech to buy it.

The correlation of Burning Rock is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burning Rock moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burning Rock Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Burning Rock can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Burning Stock Analysis

When running Burning Rock's price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC